netFormulary NHS
Northern Lincolnshire
Formulary
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
Notes:

Blood Glucose Testing Strip Guidance

 Details...
06.06.02  Expand sub section  Bisphosphonates and other drugs affecting bone metabolism
 link Link    NICE TA160: Osteoporosis - primary prevention
 link Link    NICE TA161: Osteoporosis - secondary prevention (including strontium ranelate)
06.06.02  Expand sub section  Bisphosphonates
Alendronic Acid
View adult BNF View SPC online View childrens BNF  Track Changes 		First Choice
Green

Tablets 10mg, 70mg

(including 70 mg effervescent Tablets for PEG/NG tube patient administration)

 
 
Risedronate
(once weekly)
View adult BNF View SPC online View childrens BNF  Track Changes 		Second Choice
Green

Tablets 35mg

 
 
Risedronate
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Green

5mg Tablets

 
 
Disodium Etidronate (Didronel PMO®)
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Red

200mg Tablets

 
 
Disodium Pamidronate
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Red

Injection 15mg, 90mg vial. Hospital Only

 
 
Ibandronic Acid
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Green

150mg Tablets

 
 
Ibandronic Acid
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Red

50mg Tablets. Hospital Initiated

See HYCCN Guidelines

 
 
Ibandronic Acid injection
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Red

3mg Injection Post-menopausal Osteoporosis

 
 
Zoledronic Acid (Aclasta®)
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Red

5mg Intravenous Infusion

 
 
Zoledronic Acid (Zometa®)
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Red

4mg Intravenous Infusion

 
 
Sodium Clodronate
View adult BNF View SPC online View childrens BNF  Track Changes 		Unlicensed Drug Unlicensed
Red

400mg capsules

 
 
06.06.02  Expand sub section  Denosumab
06.06.02  Expand sub section  Strontium renelate
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
SMC
 Scottish Medicines Consortium
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG

Traffic Light Status Information

Status Description

Green

 Green -Medicines suitable for routine use within primary care and Secondary care Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies  

Amber

 Amber- Medicines suitable to be prescribed in primary care after specialist /Consultant recommendation or initiation. A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust Medicines and Therapeutic Committee and approved by the Area Prescribing Committee.   

Red

 Red-Hospital initiation and continuation only  

Amber Shared Care Protocol

 AMBER SHARE CARE PROTOCOL- Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised  

Blue

 To be supplied from the appropriate commissioned provider.   

Green 2

 GREEN 2- to be prescribed by primary care only   

Grey

 GREY- NON FORMULARY (As agreed by Area Prescribing Committee)  

netFormulary